Fund
LGVAX
Price as of:
$110.65
+ $1.43
+ 1.31%
Primary Theme
fund company
Name
As of 11/21/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
22.3%
1 yr return
30.8%
3 Yr Avg Return
10.9%
5 Yr Avg Return
15.0%
Net Assets
$3.97 B
Holdings in Top 10
23.3%
52 WEEK LOW AND HIGH
$109.2
N/A
N/A
Expenses
OPERATING FEES
Expense Ratio 1.03%
SALES FEES
Front Load 5.75%
Deferred Load N/A
TRADING FEES
Turnover 54.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$1,000
IRA
$250
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 11/21/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
LGVAX - Profile
Distributions
- YTD Total Return 22.3%
- 3 Yr Annualized Total Return 10.9%
- 5 Yr Annualized Total Return 15.0%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio 0.73%
- Dividend Yield 1.3%
- Dividend Distribution Frequency None
Fund Details
-
Legal NameClearBridge Value Fund
-
Fund Family NameFRANKLIN TEMPLETON
-
Inception DateFeb 03, 2009
-
Shares OutstandingN/A
-
Share ClassA
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerSam Peters
Fund Description
The fund invests primarily in equity securities that, in the portfolio managers’ opinion, offer the potential for capital growth. The portfolio managers follow a value discipline in selecting securities, and therefore seek to purchase securities at large discounts to the portfolio managers’ assessment of the issuers’ intrinsic value. Intrinsic value, according to the portfolio managers, is the value of the company measured, to different extents depending on the type of company, on factors such as, but not limited to, the discounted value of its projected future free cash flows, the company’s ability to earn returns on capital in excess of its cost of capital, private market values of similar companies and the costs to replicate the business. The portfolio managers take a long-term approach to investing. The fund generally invests in companies with market capitalizations greater than $5 billion, but may invest in companies of any size. The fund may invest in foreign securities, including securities of emerging market issuers.
LGVAX - Performance
Return Ranking - Trailing
| Period | LGVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 22.3% | -10.4% | 43.4% | 33.49% |
| 1 Yr | 30.8% | -0.9% | 58.6% | 28.85% |
| 3 Yr | 10.9%* | -3.2% | 31.4% | 14.78% |
| 5 Yr | 15.0%* | 0.0% | 45.6% | 4.69% |
| 10 Yr | 10.2%* | 1.5% | 25.0% | 18.16% |
* Annualized
Return Ranking - Calendar
| Period | LGVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | 5.7% | -16.9% | 46.1% | 51.34% |
| 2022 | -13.6% | -64.7% | 4.6% | 65.33% |
| 2021 | 7.2% | -44.2% | 57.5% | 84.50% |
| 2020 | 4.9% | -23.2% | 285.0% | 14.50% |
| 2019 | 26.3% | -21.4% | 48.5% | 7.01% |
Total Return Ranking - Trailing
| Period | LGVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 22.3% | -10.4% | 43.4% | 33.49% |
| 1 Yr | 30.8% | -0.9% | 58.6% | 28.85% |
| 3 Yr | 10.9%* | -3.2% | 31.4% | 14.78% |
| 5 Yr | 15.0%* | 0.0% | 45.6% | 4.69% |
| 10 Yr | 10.2%* | 1.5% | 25.0% | 18.16% |
* Annualized
Total Return Ranking - Calendar
| Period | LGVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | 19.4% | -15.9% | 46.7% | 7.65% |
| 2022 | -6.4% | -42.0% | 8.5% | 57.57% |
| 2021 | 28.1% | 3.6% | 129.7% | 27.24% |
| 2020 | 11.3% | -22.6% | 304.8% | 7.89% |
| 2019 | 27.0% | -12.7% | 52.1% | 33.10% |
NAV & Total Return History
LGVAX - Holdings
Concentration Analysis
| LGVAX | Category Low | Category High | LGVAX % Rank | |
|---|---|---|---|---|
| Net Assets | 3.97 B | 126 K | 163 B | 25.09% |
| Number of Holdings | 71 | 2 | 1727 | 59.65% |
| Net Assets in Top 10 | 529 M | 433 K | 37.8 B | 38.05% |
| Weighting of Top 10 | 23.33% | 4.4% | 99.1% | 76.06% |
Top 10 Holdings
- Johnson Johnson 3.13%
- Bank of America Corp 2.85%
- American International Group Inc 2.62%
- Goldman Sachs Group Inc/The 2.25%
- Fiserv Inc 2.17%
- Energy Transfer LP 2.15%
- Noble Corp PLC 2.08%
- UnitedHealth Group Inc 2.03%
- Hess Corp 2.03%
- Gilead Sciences Inc 2.01%
Asset Allocation
| Weighting | Return Low | Return High | LGVAX % Rank | |
|---|---|---|---|---|
| Stocks | 97.17% | 7.19% | 103.40% | 70.13% |
| Cash | 2.83% | 0.00% | 36.15% | 24.17% |
| Preferred Stocks | 0.00% | 0.00% | 15.27% | 14.80% |
| Other | 0.00% | -2.59% | 36.68% | 34.38% |
| Convertible Bonds | 0.00% | 0.00% | 3.66% | 9.23% |
| Bonds | 0.00% | 0.00% | 78.06% | 13.69% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | LGVAX % Rank | |
|---|---|---|---|---|
| Financial Services | 22.93% | 0.00% | 58.05% | 19.76% |
| Healthcare | 15.77% | 0.00% | 30.08% | 66.98% |
| Energy | 14.54% | 0.00% | 54.00% | 5.01% |
| Technology | 13.98% | 0.00% | 54.02% | 23.84% |
| Consumer Cyclical | 7.45% | 0.00% | 22.74% | 28.48% |
| Industrials | 6.60% | 0.00% | 42.76% | 89.24% |
| Basic Materials | 6.06% | 0.00% | 21.69% | 10.39% |
| Utilities | 4.82% | 0.00% | 27.04% | 46.20% |
| Communication Services | 4.02% | 0.00% | 26.58% | 75.14% |
| Consumer Defense | 2.82% | 0.00% | 34.10% | 93.14% |
| Real Estate | 0.99% | 0.00% | 90.54% | 73.28% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | LGVAX % Rank | |
|---|---|---|---|---|
| US | 92.26% | 7.19% | 103.40% | 80.15% |
| Non US | 4.91% | 0.00% | 24.08% | 14.34% |
LGVAX - Expenses
Operational Fees
| LGVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 1.03% | 0.03% | 14.82% | 38.84% |
| Management Fee | 0.69% | 0.00% | 1.50% | 71.98% |
| 12b-1 Fee | 0.25% | 0.00% | 1.00% | 26.20% |
| Administrative Fee | N/A | 0.00% | 0.50% | N/A |
Sales Fees
| LGVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | 5.75% | 1.00% | 5.75% | 3.21% |
| Deferred Load | N/A | 0.95% | 5.00% | N/A |
Trading Fees
| LGVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| LGVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 54.00% | 0.00% | 488.00% | 68.35% |
LGVAX - Distributions
Dividend Yield Analysis
| LGVAX | Category Low | Category High | LGVAX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 1.28% | 0.00% | 16.67% | 3.50% |
Dividend Distribution Analysis
| LGVAX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | None | Annual | Quarterly | Annual |
Net Income Ratio Analysis
| LGVAX | Category Low | Category High | LGVAX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | 0.73% | -1.51% | 4.28% | 81.00% |
Capital Gain Distribution Analysis
| LGVAX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Semi-Annually | Annually |
Distributions History
| Date | Amount | Type |
|---|---|---|
| Dec 13, 2023 | $1.402 | OrdinaryDividend |
| Dec 13, 2023 | $1.050 | CapitalGainShortTerm |
| Dec 13, 2023 | $8.983 | CapitalGainLongTerm |
| Dec 13, 2022 | $7.267 | OrdinaryDividend |
| Dec 03, 2021 | $17.945 | OrdinaryDividend |
| Jun 17, 2021 | $0.324 | CapitalGainLongTerm |
| Dec 04, 2020 | $5.550 | OrdinaryDividend |
| Dec 05, 2019 | $0.472 | OrdinaryDividend |
| Dec 06, 2018 | $0.912 | CapitalGainShortTerm |
| Dec 06, 2018 | $0.385 | OrdinaryDividend |
| Dec 06, 2017 | $0.405 | OrdinaryDividend |
| Dec 07, 2016 | $0.664 | OrdinaryDividend |
| Dec 09, 2015 | $0.248 | OrdinaryDividend |
| Dec 10, 2014 | $0.231 | OrdinaryDividend |
| Dec 26, 2013 | $0.557 | OrdinaryDividend |
| Dec 12, 2012 | $0.623 | OrdinaryDividend |
| Dec 28, 2011 | $0.297 | OrdinaryDividend |
| Dec 10, 2009 | $0.334 | OrdinaryDividend |
LGVAX - Fund Manager Analysis
Managers
Sam Peters
Start Date
Tenure
Tenure Rank
Nov 01, 2010
11.59
11.6%
• Member of the CFA Institute • Industry since 1993 • Firm since 2005 • University of Chicago — MBA • College of William & Mary — BA in Economics • Fidelity Management & Research - Portfolio Manager, Health Care Sector Team Leader • Samuel M. Peters Investment Advisors - Founder • Eppler, Guerin & Turner - Financial Consultant - See more at: https://www.clearbridge.com/about/team/portfolio-management/peters-sam.html?team=portfolio_management#sthash.9Ysk0KIZ.dpuf
Jean Yu
Start Date
Tenure
Tenure Rank
May 15, 2013
9.05
9.1%
Jean Yu, CFA, PhD Managing Director, Portfolio Manager Experience: 14 years of investment industry experience Joined ClearBridge, LLC (f/k/a Legg Mason Capital Management, LLC) in 2002 Member of the CFA Institute ISO Health Care Group - Senior Business Analyst PhD in Molecular Biology from Columbia University MBA in Health Sector Management and Finance from Duke University MD from Beijing Medical University
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.05 | 86.59 | 8.09 | 6.71 |